ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Canada : TSX and TSX Venture Exchange Share Prices, Indexes & News

TSX Composite ETF 34.98-0.1%

TSX 60 ETF 33.26-0.1%

Canadian Stock Search

Look up Canadian Stocks, Markets, News, Forex and more

TSX Composite ETF

34.98
-0.02
-0.06%

TSX 60 ETF

33.26
-0.03
-0.09%

Manulife

32.60
-0.07
-0.21%

Bell Canada

46.31
-0.3
-0.64%

Toronto Stock Exchange

Name Price Change %
Royal Bank of Canada134.34-0.22%
Toronto Dominion Bank80.23-1.40%
Bank of Nova Scotia67.28-0.24%
Suncor Energy49.16+0.61%
Canadian Natural Resources99.36+1.10%
Barrick Gold21.17-0.89%
Imperial Oil91.56+0.22%
Augusta Gold0.88-1.12%
Bank of Montreal127.17+0.05%
Canadian National Railway176.05+1.02%
Canadian Imperial Bank o...67.17+0.72%

Canadian Dollar FOREX

More FOREX
Name Price Change
USD CAD1.3540+0.0004
EUR CAD1.4721+0.0003
CAD JPY110.2140+0.0220
GBP CAD1.7229+0.0004
AUD CAD0.8879+0.0005
CAD CHF0.6560+0.0003
CAD HKD5.7763-0.0007
CAD SEK7.7057-0.0014
NZD CAD0.8229-0.0004
CAD KRW987.9534-0.7660
CAD SGD0.9890-0.0005

Commodities Prices

More Commodities
Name Market Price %
GoldPM2,161.76+0.00%
SilverPM25.14+0.30%
PlatinumCCOM916.71-0.15%
CopperCCOM4.14+0.08%
Brent Crude OilCCOM86.33-0.05%
GasolineCCOM82.13-0.11%
Natural GasCCOM1.82+0.33%

Market News

More Market News

Breakthrough in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion: Release of Positive Results..

The world's first non-surgical cervical HSIL treatment validated by an international Phase III clinical study with proven efficacy;The response rate increased by 89.4% compared to the placebo control group, with a low incidence of adverse events;The China new drug application submission is expected in Q2 2024, while ex-China product development is in active progress.SHANGHAI, March 18, 2024 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a...

22:07Waterdrop Launches Groundbreaking X Series Reverse Osmosis System, Redefining Standards for Clean, Healthy, and..
21:13TEHTRIS unveils exclusive background and evidence of RosyStyle Affair
21:00Cambridge Semantics named to the esteemed list of Companies that Matter in Knowledge Management
20:56ICP DAS-BMP Secures Pivotal TPU Deals with Medical Materials Leaders in U.S. and Japan, Boosts Product..
20:45Segway Collaborates with NVIDIA to Introduce NVIDIA Isaac-powered Nova Orin Developer Kit for Autonomous Mobile..
20:23Groq® Is Still Faster
20:13Island Pacific Seafood Market & Filipino Grocery Store Heats Up National Lumpia Day with Exciting Lumpia Eating..
20:07Healthpitality Launches to Transform Healthcare for Hospitality Professionals Nationwide Leveraging Experience,..
20:00Wiwynn Showcases Innovations on NVIDIA GB200 NVL72 at GTC 2024
19:42IT Asset Disposition (ITAD) Market size to grow by USD 14.85 billion between 2024 and 2028, 3 Step IT Group Oy..
19:20KCC announces the strategic hiring of Gena Sullivan and Shawn Launier
19:13Databricks and NVIDIA Deepen Collaboration to Accelerate Data and AI Workloads with the Data Intelligence..
19:00STATEMENT OF THE DWIGHT D. OPPERMAN FOUNDATION ABOUT THE RBG AWARD

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com